Trump Unveils Up To 200% Tariff On Generic Drugs By 2028: What It Means For India

US President Donald Trump on Wednesday unveiled a phased tariff plan for imported generic medicines, giving manufacturers a two-year window to shift production to the United States before imposing steep import duties that could significantly affect India's pharmaceutical exports.

Pharmaceutical exports could end up 18% lower compared to a scenario without tariffs.

The tariff, which aims to bolster US pharmaceutical production, is set to go into effect in August 2028.

As a result of that probe, brand-name pharmaceuticals will face tariffs as high as 100 percent at the end of the month, but generic drugs are currently excluded from the duties, among a raft of exemptions.